WARD Prospective

WARD Prospective

Study design
Prospective study/cohort
Sample size
3095 participants
Study sites

Rigshospitalet

Inclusion criteria
  • Adult participants (≥18 years)
  • Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
  • Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
Study procedures

Continuous wireless vital sign monitoring with real-time alerts was introduced in clinical care. Researchers assessed data quality and clinical users’ experience as implementation progressed.

Outcome

Planned primary outcomes: proportion of patients with adequate simultaneous heart rate, breathing rate and oxygen saturation data, and staff satisfaction with monitoring.

Trial registration
NCT05378139

–  Read more